BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31033190)

  • 1. Genomic Association Analysis Reveals Variants Associated With Blood Pressure Response to Beta-Blockers in European Americans.
    Singh S; El Rouby N; McDonough CW; Gong Y; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Turner ST; Cooper-DeHoff RM; Johnson JA
    Clin Transl Sci; 2019 Sep; 12(5):497-504. PubMed ID: 31033190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome Wide Analysis Approach Suggests Chromosome 2 Locus to be Associated with Thiazide and Thiazide Like-Diuretics Blood Pressure Response.
    Singh S; McDonough CW; Gong Y; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Turner ST; Cooper-DeHoff RM; Johnson JA
    Sci Rep; 2019 Nov; 9(1):17323. PubMed ID: 31754133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to β-Blockers in Hypertensive African Americans.
    Gong Y; Wang Z; Beitelshees AL; McDonough CW; Langaee TY; Hall K; Schmidt SO; Curry RW; Gums JG; Bailey KR; Boerwinkle E; Chapman AB; Turner ST; Cooper-DeHoff RM; Johnson JA
    Hypertension; 2016 Mar; 67(3):556-63. PubMed ID: 26729753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-Wide Meta-Analysis of Blood Pressure Response to β
    Singh S; Warren HR; Hiltunen TP; McDonough CW; El Rouby N; Salvi E; Wang Z; Garofalidou T; Fyhrquist F; Kontula KK; Glorioso V; Zaninello R; Glorioso N; Pepine CJ; Munroe PB; Turner ST; Chapman AB; Boerwinkle E; Johnson JA; Gong Y; Cooper-DeHoff RM
    J Am Heart Assoc; 2019 Aug; 8(16):e013115. PubMed ID: 31423876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β-Blockers.
    Shahin MH; Conrado DJ; Gonzalez D; Gong Y; Lobmeyer MT; Beitelshees AL; Boerwinkle E; Gums JG; Chapman A; Turner ST; Cooper-DeHoff RM; Johnson JA
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of plasma MicroRNA on antihypertensive response to beta blockers in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studies.
    Solayman MH; Langaee TY; Gong Y; Shahin MH; Turner ST; Chapman AB; Gums JG; Boerwinkle E; Beitelshees AL; El-Hamamsy M; El-Wakeel L; Cooper-DeHoff RM; Badary OA; Johnson JA
    Eur J Pharm Sci; 2019 Apr; 131():93-98. PubMed ID: 30753892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies.
    McDonough CW; Warren HR; Jack JR; Motsinger-Reif AA; Armstrong ND; Bis JC; House JS; Singh S; El Rouby NM; Gong Y; Mychaleckyj JC; Rotroff DM; Benavente OR; Caulfield MJ; Doria A; Pepine CJ; Psaty BM; Glorioso V; Glorioso N; Hiltunen TP; Kontula KK; Arnett DK; Buse JB; Irvin MR; Johnson JA; Munroe PB; Wagner MJ; Cooper-DeHoff RM
    Clin Pharmacol Ther; 2021 Sep; 110(3):723-732. PubMed ID: 34231218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β
    Shahin MH; Rouby NE; Conrado DJ; Gonzalez D; Gong Y; Lobmeyer MT; Beitelshees AL; Boerwinkle E; Gums JG; Chapman A; Turner ST; Pepine CJ; Cooper-DeHoff RM; Johnson JA
    J Clin Pharmacol; 2019 Nov; 59(11):1462-1470. PubMed ID: 31090079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.
    Gong Y; McDonough CW; Beitelshees AL; El Rouby N; Hiltunen TP; O'Connell JR; Padmanabhan S; Langaee TY; Hall K; Schmidt SO; Curry RW; Gums JG; Donner KM; Kontula KK; Bailey KR; Boerwinkle E; Takahashi A; Tanaka T; Kubo M; Chapman AB; Turner ST; Pepine CJ; Cooper-DeHoff RM; Johnson JA
    J Hypertens; 2015 Nov; 33(11):2278-85. PubMed ID: 26425837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).
    McDonough CW; Magvanjav O; Sá ACC; El Rouby NM; Dave C; Deitchman AN; Kawaguchi-Suzuki M; Mei W; Shen Y; Singh RSP; Solayman M; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Webb A; Scherer SE; Sadee W; Turner ST; Cooper-DeHoff RM; Gong Y; Johnson JA
    Circ Genom Precis Med; 2018 Apr; 11(4):e001854. PubMed ID: 29650764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.
    Gong Y; McDonough CW; Wang Z; Hou W; Cooper-DeHoff RM; Langaee TY; Beitelshees AL; Chapman AB; Gums JG; Bailey KR; Boerwinkle E; Turner ST; Johnson JA
    Circ Cardiovasc Genet; 2012 Dec; 5(6):686-91. PubMed ID: 23087401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
    Vandell AG; Lobmeyer MT; Gawronski BE; Langaee TY; Gong Y; Gums JG; Beitelshees AL; Turner ST; Chapman AB; Cooper-DeHoff RM; Bailey KR; Boerwinkle E; Pepine CJ; Liggett SB; Johnson JA
    Hypertension; 2012 Oct; 60(4):957-64. PubMed ID: 22949529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide Association Study of Apparent Treatment-Resistant Hypertension in the CHARGE Consortium: The CHARGE Pharmacogenetics Working Group.
    Irvin MR; Sitlani CM; Floyd JS; Psaty BM; Bis JC; Wiggins KL; Whitsel EA; Sturmer T; Stewart J; Raffield L; Sun F; Liu CT; Xu H; Cupples AL; Tanner RM; Rossing P; Smith A; Zilhão NR; Launer LJ; Noordam R; Rotter JI; Yao J; Li X; Guo X; Limdi N; Sundaresan A; Lange L; Correa A; Stott DJ; Ford I; Jukema JW; Gudnason V; Mook-Kanamori DO; Trompet S; Palmas W; Warren HR; Hellwege JN; Giri A; O'donnell C; Hung AM; Edwards TL; Ahluwalia TS; Arnett DK; Avery CL
    Am J Hypertens; 2019 Nov; 32(12):1146-1153. PubMed ID: 31545351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of two different beta-blockers on 24-hour blood pressure control.
    Sarafidis P; Bogojevic Z; Basta E; Kirstner E; Bakris GL
    J Clin Hypertens (Greenwich); 2008 Feb; 10(2):112-8. PubMed ID: 18259123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-blockers: a review of their pharmacological and physiological diversity in hypertension.
    Ripley TL; Saseen JJ
    Ann Pharmacother; 2014 Jun; 48(6):723-33. PubMed ID: 24687542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension.
    Wong GW; Boyda HN; Wright JM
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007451. PubMed ID: 26961574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome Wide Association Study Identifies the
    Singh S; McDonough CW; Gong Y; Alghamdi WA; Arwood MJ; Bargal SA; Dumeny L; Li WY; Mehanna M; Stockard B; Yang G; de Oliveira FA; Fredette NC; Shahin MH; Bailey KR; Beitelshees AL; Boerwinkle E; Chapman AB; Gums JG; Turner ST; Cooper-DeHoff RM; Johnson JA
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29523524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations.
    Franceschini N; Fox E; Zhang Z; Edwards TL; Nalls MA; Sung YJ; Tayo BO; Sun YV; Gottesman O; Adeyemo A; Johnson AD; Young JH; Rice K; Duan Q; Chen F; Li Y; Tang H; Fornage M; Keene KL; Andrews JS; Smith JA; Faul JD; Guangfa Z; Guo W; Liu Y; Murray SS; Musani SK; Srinivasan S; Velez Edwards DR; Wang H; Becker LC; Bovet P; Bochud M; Broeckel U; Burnier M; Carty C; Chasman DI; Ehret G; Chen WM; Chen G; Chen W; Ding J; Dreisbach AW; Evans MK; Guo X; Garcia ME; Jensen R; Keller MF; Lettre G; Lotay V; Martin LW; Moore JH; Morrison AC; Mosley TH; Ogunniyi A; Palmas W; Papanicolaou G; Penman A; Polak JF; Ridker PM; Salako B; Singleton AB; Shriner D; Taylor KD; Vasan R; Wiggins K; Williams SM; Yanek LR; Zhao W; Zonderman AB; Becker DM; Berenson G; Boerwinkle E; Bottinger E; Cushman M; Eaton C; Nyberg F; Heiss G; Hirschhron JN; Howard VJ; Karczewsk KJ; Lanktree MB; Liu K; Liu Y; Loos R; Margolis K; Snyder M; ; Psaty BM; Schork NJ; Weir DR; Rotimi CN; Sale MM; Harris T; Kardia SL; Hunt SC; Arnett D; Redline S; Cooper RS; Risch NJ; Rao DC; Rotter JI; Chakravarti A; Reiner AP; Levy D; Keating BJ; Zhu X
    Am J Hum Genet; 2013 Sep; 93(3):545-54. PubMed ID: 23972371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping genetic variants associated with beta-adrenergic responses in inbred mice.
    Hersch M; Peter B; Kang HM; Schüpfer F; Abriel H; Pedrazzini T; Eskin E; Beckmann JS; Bergmann S; Maurer F
    PLoS One; 2012; 7(7):e41032. PubMed ID: 22859963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
    McDonough CW; Gillis NK; Alsultan A; Chang SW; Kawaguchi-Suzuki M; Lang JE; Shahin MH; Buford TW; El Rouby NM; Sá AC; Langaee TY; Gums JG; Chapman AB; Cooper-DeHoff RM; Turner ST; Gong Y; Johnson JA
    PLoS One; 2013; 8(10):e76984. PubMed ID: 24116192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.